Independent Association between Sleep Fragmentation and Dyslipidemia in Patients with Obstructive Sleep Apnea

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Qian, Yingjun ^a   Yi, Hongliang ^a   Zou, Jianyin ^a   Meng, Lili ^a   Tang, Xulan ^a   Zhu, Huaming ^a   Yu, Dongzhen ^a   Zhou, Huiqun ^a   Su, Kaiming ^a   Guan, Jian ^a   Yin, Shankai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BLOOD ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; FEMALE; HUMAN; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP DEPRIVATION; SLEEP DISORDERED BREATHING;

ADULT; BLOOD CHEMICAL ANALYSIS; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; SLEEP DEPRIVATION;

EID: 84968884510     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep26089     Document Type: Article

References (38)

1. Young, T. et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328, 1230-1235 (1993).
2. Peppard, P. E. et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177, 1006-1014 (2013).
3. Cuhadaroglu, C., Utkusavas, A., Ozturk, L., Salman, S. & Ece, T. Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea. Lung 187, 75-81 (2009).
4. Drager, L. F., Jun, J. & Polotsky, V. Y. Obstructive sleep apnea and dyslipidemia: implications for atherosclerosis. Curr Opin Endocrinol Diabetes Obes 17, 161-165 (2010).
5. Knauert, M., Naik, S., Gillespie, M. B. & Kryger, M. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World J Otorhinolar Head Neck 1, 17-27 (2015).
6. Kono, M. et al. Obstructive sleep apnea syndrome is associated with some components of metabolic syndrome. Chest 131, 1387-1392 (2007).
7. Dewan, N. A., Nieto, F. J. & Somers, V. K. Intermittent hypoxemia and OSA: implications for comorbidities. Chest 147, 266-274 (2015).
8. Adedayo, A. M. et al. Obstructive sleep apnea and dyslipidemia: evidence and underlying mechanism. Sleep Breath 18, 13-18 (2014).
9. Li, J. et al. Hyperlipidemia and lipid peroxidation are dependent on the severity of chronic intermittent hypoxia. J Appl Physiol (1985) 102, 557-563 (2007).
10. Chou, Y. T. et al. Hyperlipidaemia in patients with sleep-related breathing disorders: prevalence & risk factors. Indian J Med Res 131, 121-125 (2010).
11. Perry, J. C. et al. Consequences of subchronic and chronic exposure to intermittent hypoxia and sleep deprivation on cardiovascular risk factors in rats. Respir Physiol Neurobiol 156, 250-258 (2007).
12. Togeiro, S. M. et al. Consequences of obstructive sleep apnea on metabolic profile: a Population-Based Survey. Obesity 21, 847-851 (2013).
13. Wehrens, S. M., Hampton, S. M., Finn, R. E. & Skene, D. J. Effect of total sleep deprivation on postprandial metabolic and insulin responses in shift workers and non-shift workers. J Endocrinol 206, 205-215 (2010).
14. Taheri, S., Lin, L., Austin, D., Young, T. & Mignot, E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med 1, e62 (2004).
15. Ekstedt, M., Akerstedt, T. & Soderstrom, M. Microarousals during sleep are associated with increased levels of lipids, cortisol, and blood pressure. Psychosom Med 66, 925-931 (2004).
16. Gangwisch, J. E. et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension 47, 833-839 (2006).
17. Trzepizur, W. et al. Independent association between nocturnal intermittent hypoxemia and metabolic dyslipidemia. Chest 143, 1584-1589 (2013).
18. Andersen, M. L. et al. Effects of paradoxical sleep deprivation on blood parameters associated with cardiovascular risk in aged rats. Exp Gerontol 39, 817-824 (2004).
19. Chen, Z. et al. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. BMJ 303, 276-282 (1991).
20. Stamler, J., Vaccaro, O., Neaton, J. D. & Wentworth, D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16, 434-444 (1993).
21. Zhang, L. et al. The impact of dyslipidaemia on cardiovascular mortality in individuals without a prior history of diabetes in the DECODE Study. Atherosclerosis 206, 298-302 (2009).
22. Guan, J. et al. Distinct severity stages of obstructive sleep apnoea are correlated with unique dyslipidaemia: large-scale observational study. Thorax, doi: 10.1136/thoraxjnl-2015-207403 (2016).
23. Newman, A. B. et al. Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154, 50-59 (2001).
24. Roche, F. et al. Obstructive sleep apnoea/hypopnea influences high-density lipoprotein cholesterol in the elderly. Sleep Med 10, 882-886 (2009).
25. Nadeem, R. et al. Effect of CPAP treatment for obstructive sleep apnea hypopnea syndrome on lipid profile: a meta-regression analysis. J Clin Sleep Med 10, 1295-1302 (2014).
26. Lin, M. T. et al. Beneficial effect of continuous positive airway pressure on lipid profiles in obstructive sleep apnea: a meta-analysis. Sleep Breath 19, 809-817 (2015).
27. van den Berg, J. F. et al. Long sleep duration is associated with serum cholesterol in the elderly: the Rotterdam Study. Psychosom Med 70, 1005-1011 (2008).
28. Spath-Schwalbe, E., Gofferje, M., Kern, W., Born, J. & Fehm, H. L. Sleep disruption alters nocturnal ACTH and cortisol secretory patterns. Biol Psychiatry 29, 575-584 (1991).
29. Brindley, D. N., McCann, B. S., Niaura, R., Stoney, C. M. & Suarez, E. C. Stress and lipoprotein metabolism: modulators and mechanisms. Metabolism 42, 3-15 (1993).
30. Carreras, A. et al. Effect of resveratrol on visceral white adipose tissue inflammation and insulin sensitivity in a mouse model of sleep apnea. Int J Obes 39, 418-423 (2015).
31. Trammell, R. A., Verhulst, S. & Toth, L. A. Effects of sleep fragmentation on sleep and markers of inflammation in mice. Comp Med 64, 13-24 (2014).
32. Esteve, E., Ricart, W. & Fernandez-Real, J. M. Dyslipidemia and inflammation: an evolutionary conserved mechanism. Clin Nutr 24, 16-31 (2005).
33. Palma, B. D., Tiba, P. A., Machado, R. B., Tufik, S. & Suchecki, D. Immune outcomes of sleep disorders: the hypothalamic-pituitary-adrenal axis as a modulatory factor. Rev Bras Psiquiatr 29 Suppl 1, S33-38 (2007).
34. Benn, M., Nordestgaard, B. G., Grande, P., Schnohr, P. & Tybjaerg-Hansen, A. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55, 2833-2842 (2010).
35. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421 (2002).
36. Iber C., Ancoli-Israel S., Chesson A. & Quan S. F. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications 1st edn. (American Academy of Sleep Medicine, 2007).
37. Zhou, B. F. Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults-study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed Environ Sci 15, 83-96 (2002).
38. Bonora, E. et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23, 57-63 (2000).